Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Liabilities and Shareholders Equity (2020 - 2025)

PROCEPT BioRobotics has reported Liabilities and Shareholders Equity over the past 6 years, most recently at $508.1 million for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $508.1 million for Q4 2025, down 4.86% from a year ago — trailing twelve months through Dec 2025 was $2.1 billion (up 23.22% YoY), and the annual figure for FY2025 was $508.1 million, down 4.86%.
  • Liabilities and Shareholders Equity for Q4 2025 was $508.1 million at PROCEPT BioRobotics, down from $511.5 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for PRCT hit a ceiling of $534.0 million in Q4 2024 and a floor of $272.4 million in Q2 2023.
  • Median Liabilities and Shareholders Equity over the past 5 years was $374.2 million (2024), compared with a mean of $391.9 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 167.54% in 2021 and later dropped 12.38% in 2023.
  • PROCEPT BioRobotics' Liabilities and Shareholders Equity stood at $337.0 million in 2021, then fell by 8.22% to $309.3 million in 2022, then soared by 30.84% to $404.7 million in 2023, then soared by 31.95% to $534.0 million in 2024, then fell by 4.86% to $508.1 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $508.1 million (Q4 2025), $511.5 million (Q3 2025), and $513.1 million (Q2 2025) per Business Quant data.